Grace Zhou, is professor, co-founder, CEO and Chairman of ImmVira Group with over 25 years of experience in the academic research and pharmaceutical industry. Dr. Zhou was awarded the Women in Science Award by International Society for Antiviral Research in 2019 and received special governmental allowances of the PRC State Council in 1998.
Grace Zhou received her Ph. Degree from the Shanghai Institute of Biochemistry, Chinese Academy of Sciences in 1998. She was a former associate professor of the Department of Microbiology at the University of Chicago. With her studies focused on the control of innate immune responses in herpesvirus infected cells, the molecular basis of oHSV latent infection, genetic engineering of anti-viral and therapeutic exosomes, Dr. Zhou is a national award-winning scientist with extensive years of academic and research experience in the field of oncology, virology and immunology. Prior to founding ImmVira, Dr. Zhou conducted research with the focus of her studies in the field of virology. In particular, she had conducted research in gene regulation during HSV-1 lytic and latent infection, HSV for cancer treatment in University of Chicago until 2013. She is the co-author of over 50 academic publications and the holder of over 17 patents.
Thomas E. Shenk Ph.D is a Distinguished Professor at Princeton University. He served for many years on the BOD of Merck. He published extensively on the biologic properties of human herpesviruses and holds numerous patents. He is the recipient of numerous awards including membership in the National Academy of Sciences US, National Academy of Medicine US.
Richard J Whitley MD is a Distinguished Professor of Pediatrics, Microbiology and Medicine at the University of Alabama at Birmingham. He is considered to be one of the foremost experts in the role of viruses in human infections and is the recipient on numerous awards and recgnions. He a member of the BOD of Gilead and chairs numerous panels at NIH.
Ralph R. Weichselbaum MD is a Distinguished Service Professor and Chairman of the Department of Radiation Oncology at the University of Chicago. He is widely recognized as a world expert in cancer treatment and is the recipient of numerous awards and recognition including membership in the National Academy of Medicine. He is the author of numerous publications and patents related to cancer treatment.